Diamond Capital Company logo

Diamond Capital Company

Europe, Geneve, Switzerland, Geneva

Description

Diamond Capital Company offers fixed income, equity, and alternative investment opportunities to clients around the world.

Investor Profile

Diamond Capital Company has made 4 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (50%)
  • Series Unknown (25%)
  • Series D (25%)

Country Focus

  • United States (100%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Operating Systems
  • Real Time
  • Software
  • Therapeutics
  • Biopharma
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Diamond Capital Company frequently co-invest with?

SB
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
Domain Associates
North America, California, United States, San Diego
Co-Investments: 1
J.P. Morgan Securities Inc.
North America, New York, United States, New York
Co-Investments: 1
Noventi
North America, California, United States, Newark
Co-Investments: 1
Kleiner Perkins
North America, California, United States, Menlo Park
Co-Investments: 1
TPG
North America, California, United States, San Francisco
Co-Investments: 1
DeA Capital
Europe, Lombardia, Italy, Milan
Co-Investments: 1
Nexit Ventures
Europe, Southern Finland, Finland, Helsinki
Co-Investments: 1
HealthCap
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 1
Advanced Technology Ventures
North America, California, United States, Menlo Park
Co-Investments: 1

What are some of recent deals done by Diamond Capital Company?

Ecrio

Cupertino, California, United States

Ecrio develops a framework to upgrade common applications into communication-rich applications for multiple operating systems and phones.

Operating SystemsReal TimeSoftware
Series BAug 2, 2005
Amount Raised: $3,000,000
Affymax

Cupertino, California, United States

Affymax is a biopharmaceutical company.

BiopharmaBiotechnologyHealth Care
Series DJul 18, 2005
Amount Raised: $60,000,000
Five Prime Therapeutics

San Francisco, California, United States

FivePrime is a clinical-stage biotechnology company that develops treatments for cancers.

BiotechnologyHealth CareMedicalTherapeutics
Series UnknownFeb 8, 2005
Amount Raised: $45,000,000
Acuity Pharmaceuticals

Philadelphia, Pennsylvania, United States

Acuity Pharmaceuticals product-focused ophthalmic pharmaceutical company applying its proprietary technology to the treatment.

Health CareMedicalPharmaceutical
Series BOct 7, 2004
Amount Raised: $15,000,000